Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HCA Health Inc (HCA) vs JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Price & Performance

HCA Health IncTrade
JPMorgan Nasdaq Equity Premium Income ETFTrade

Price performance (Past 24H)

Key statistics

HCA Health Inc vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? HCA Health Inc trades at $448.62 (market cap $96.35B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $61.08 (market cap $44.49B). The key difference: HCA Health Inc is far larger — about 2.2× JPMorgan Nasdaq Equity Premium Income ETF's market cap, and HCA Health Inc pays a 0.7% dividend while JPMorgan Nasdaq Equity Premium Income ETF pays none. Which is the better fit depends on your goals.

HCAJEPQ
Market Cap
$96.35B$44.49B
Volume
1,079,4535,681,789
Sector
HealthIncome / Options Overlay
52-Week High
$545.13$61.46
52-Week Low
$361.32$53.77
Typical Hold Time
76 Days—
Enterprise Value
$146.88B—
Dividend Yield
0.7%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HCA Health Inc

HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.

The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ trades at $61.03, down 0.39% on the day, with a bullish technical signal from moving averages despite neutral oscillators. The ETF maintains strong income generation through its covered-call strategy, with recent dividends ranging from $0.57 to $0.70 per share. Financial media coverage highlights JEPQ's 11% estimated annualized yield and suitability for retirement income, though analysts note the trade-off between high current income and limited price appreciation potential.

JEPQ offers exceptional current income for investors seeking monthly cash flow, with its covered-call strategy performing well in volatile markets. However, the ETF faces risks from market volatility dependence and potential principal erosion if yield chasing outweighs total return considerations. Institutional interest remains strong, with Envestnet increasing its position by 8.2% recently.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HCA
100% Buy0% Sell
Avg holding period · 76 Days
JEPQ
71% Buy29% Sell

Top news

Latest headlines on both assets

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA →

About JPMorgan Nasdaq Equity Premium Income ETF

JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.

Read more on JEPQ →